TriSalus Life Sciences, Inc. TLSI Return on assets
Return on assets at other companies
Other financials
Where this comes from
Calculated from TriSalus Life Sciences, Inc.’s reported figures.
Based on trailing twelve months.
The official record: TriSalus Life Sciences, Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about TriSalus Life Sciences, Inc.'s return on assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is TriSalus Life Sciences, Inc.'s return on assets?
- TriSalus Life Sciences, Inc. (TLSI) reported return on assets of -54.8% in Q1 2026.
- How has TriSalus Life Sciences, Inc.'s return on assets changed year-over-year?
- TriSalus Life Sciences, Inc.'s return on assets increased by 53.1% year-over-year, from -117% to -54.8%.
- What is the long-term trend for TriSalus Life Sciences, Inc.'s return on assets?
- Over 4 years (2021 to 2025), TriSalus Life Sciences, Inc.'s return on assets has grown at a 189.0% compound annual growth rate (CAGR), from 1.9% to -132.3%.
- What does return on assets mean?
- Trailing-twelve-month net income divided by average total assets. Measures how efficiently the asset base generates profit, independent of how those assets are financed. Computed as net income over average total assets — note this is OpenCapital's standard definition and may differ from data vendors that use alternative numerators.